findmyKOL
Clinical trialNCT04870944RecruitingPhase 1/PHASE2Interventional

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

SponsorChildren's Oncology GroupEnrollment63Diffuse Midline Glioma, H3 K27-AlteredMetastatic Malignant Neoplasm in the Central Nervous SystemRecurrent Diffuse Intrinsic Pontine GliomaRecurrent Diffuse Midline Glioma, H3 K27-AlteredRecurrent LymphomaRecurrent Malignant Solid Neoplasm+4 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This phase I/II trial evaluates the best dose, side effects and possible benefit of CBL0137 in treating patients with solid tumors, including central nervous system (CNS) tumors or lymphoma that has come back (relapsed) or does not respond to treatment (refractory). Drugs, such as CBL0137, block signals passed from one molecule to another inside a cell. Blocking these signals can affect many functions of the cell, including cell division and cell death, and may kill cancer cells.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Sydney Children'S Hospital

    Randwick, New South Wales, Australia

    Suspended
United States
  • Children'S Hospital of Alabama

    Birmingham, Alabama, United States

    Girish Dhall
    Recruiting
  • Phoenix Childrens Hospital

    Phoenix, Arizona, United States

    Alok K. Kothari
    Recruiting
  • Children'S Hospital Los Angeles

    Los Angeles, California, United States

    Fariba Navid
    Recruiting
  • Children'S Hospital of Orange County

    Orange, California, United States

    Josephine H. Haduong
    Recruiting
  • Ucsf Medical Center-Mission Bay

    San Francisco, California, United States

    Kieuhoa T. Vo
    Recruiting
  • Children'S Hospital Colorado

    Aurora, Colorado, United States

    Margaret E. Macy
    Recruiting
  • Children'S National Medical Center

    Washington D.C., District of Columbia, United States

    AeRang Kim
    Recruiting
  • Johns Hopkins All Children'S Hospital

    St. Petersburg, Florida, United States

    Jonathan L. Metts
    Recruiting
  • Children'S Healthcare of Atlanta - Arthur M Blank Hospital

    Atlanta, Georgia, United States

    Jason R. Fangusaro
    Recruiting
  • Lurie Children'S Hospital-Chicago

    Chicago, Illinois, United States

    Elizabeth A. Sokol
    Recruiting
  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois, United States

    Ami V. Desai
    Recruiting
  • Riley Hospital for Children

    Indianapolis, Indiana, United States

    Brian D. Weiss
    Recruiting
  • Johns Hopkins University/sidney Kimmel Cancer Center

    Baltimore, Maryland, United States

    Christine A. Pratilas
    Recruiting
  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

    Recruiting
  • C S Mott Children'S Hospital

    Ann Arbor, Michigan, United States

    Rajen Mody
    Recruiting
  • University of Minnesota/masonic Cancer Center

    Minneapolis, Minnesota, United States

    Robin L. Williams
    Recruiting
  • Children'S Mercy Hospitals and Clinics

    Kansas City, Missouri, United States

    Kevin F. Ginn
    Recruiting
  • Washington University School of Medicine

    St Louis, Missouri, United States

    Shalini Shenoy
    Recruiting
  • Roswell Park Cancer Institute

    Buffalo, New York, United States

    Clare J. Twist
    Recruiting
  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

    Julia L. Glade Bender
    Recruiting
  • Nyp/columbia University Medical Center/herbert Irving Comprehensive Cancer Center

    New York, New York, United States

    Nobuko Hijiya
    Recruiting
  • New York Medical College

    Valhalla, New York, United States

    Recruiting
  • Duke University Medical Center

    Durham, North Carolina, United States

    Jessica M. Sun
    Recruiting
  • Cincinnati Children'S Hospital Medical Center

    Cincinnati, Ohio, United States

    Joseph G. Pressey
    Recruiting
  • Oregon Health and Science University

    Portland, Oregon, United States

    Bill H. Chang
    Recruiting
  • Children'S Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States

    Theodore W. Laetsch
    Recruiting
  • Children'S Hospital of Pittsburgh of Upmc

    Pittsburgh, Pennsylvania, United States

    Andrew Bukowinski
    Recruiting
  • Saint Jude Children'S Research Hospital

    Memphis, Tennessee, United States

    Dana Tlais
    Recruiting
  • Ut Southwestern/simmons Cancer Center-Dallas

    Dallas, Texas, United States

    Laura J. Klesse
    Recruiting
  • Cook Children'S Medical Center

    Fort Worth, Texas, United States

    Sibo Zhao
    Recruiting
  • Baylor College of Medicine/dan L Duncan Comprehensive Cancer Center

    Houston, Texas, United States

    Jennifer H. Foster
    Recruiting
  • Primary Children'S Hospital

    Salt Lake City, Utah, United States

    Matthew Dietz
    Recruiting
  • Seattle Children'S Hospital

    Seattle, Washington, United States

    Katherine G. Tarlock
    Recruiting
  • Children'S Hospital of Wisconsin

    Milwaukee, Wisconsin, United States

    Sarah Rumler
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

FACT Complex-targeting Curaxin CBL0137
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Jan 2022
Primary completion
31 Dec 2026
Completion
31 Dec 2026
Last update posted
5 May 2026
Registered enrollment
63
Registry id
NCT04870944

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.